Hestia Insight Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Hestia Insight Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $8.0K | Mar 2, 2026 |
| FY2025 | Nov 30, 2024 | $1.25M | Mar 2, 2026 |
| FY2023 | Nov 30, 2023 | $113.4K | Mar 19, 2025 |
| FY2023 | Nov 30, 2022 | $15.0K | Mar 14, 2024 |
| FY2022 | Nov 30, 2021 | $28.5K | Feb 24, 2023 |
| FY2021 | Nov 30, 2020 | $142.9K | Feb 25, 2022 |
| FY2020 | Nov 30, 2019 | $120.0K | Mar 15, 2021 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Nov 30, 2023 | $113.4K | Mar 14, 2024 |
| FY2023 | Nov 30, 2022 | $15.0K | Mar 14, 2024 |
| FY2022 | Nov 30, 2021 | $27.0K | Feb 24, 2023 |
| FY2021 | Nov 30, 2020 | $142.9K | Feb 25, 2022 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | ($943.4K) | Mar 2, 2026 |
| FY2025 | Nov 30, 2024 | $642.2K | Mar 2, 2026 |
| FY2023 | Nov 30, 2023 | ($500.4K) | Mar 19, 2025 |
| FY2023 | Nov 30, 2022 | ($1.71M) | Mar 14, 2024 |
| FY2022 | Nov 30, 2021 | ($9.77M) | Feb 24, 2023 |
| FY2021 | Nov 30, 2020 | $11.52M | Feb 25, 2022 |
| FY2021 | Nov 30, 2019 | ($215.6K) | Feb 25, 2022 |
| FY2021 | Nov 30, 2018 | ($86.1K) | Feb 25, 2022 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | ($304.9K) | Mar 2, 2026 |
| FY2025 | Nov 30, 2024 | $851.5K | Mar 2, 2026 |
| FY2023 | Nov 30, 2023 | ($301.6K) | Mar 19, 2025 |
| FY2023 | Nov 30, 2022 | ($348.3K) | Mar 14, 2024 |
| FY2022 | Nov 30, 2021 | ($220.2K) | Feb 24, 2023 |
| FY2021 | Nov 30, 2020 | ($6.4K) | Feb 25, 2022 |
| FY2020 | Nov 30, 2019 | ($165.7K) | Mar 15, 2021 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $312.9K | Mar 2, 2026 |
| FY2025 | Nov 30, 2024 | $398.4K | Mar 2, 2026 |
| FY2023 | Nov 30, 2023 | $415.1K | Mar 19, 2025 |
| FY2023 | Nov 30, 2022 | $363.3K | Mar 14, 2024 |
| FY2022 | Nov 30, 2021 | $247.2K | Feb 24, 2023 |
| FY2021 | Nov 30, 2020 | $149.3K | Feb 25, 2022 |
| FY2020 | Nov 30, 2019 | $285.7K | Mar 15, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | ($134.3K) | Mar 2, 2026 |
| FY2025 | Nov 30, 2024 | ($168.8K) | Mar 2, 2026 |
| FY2023 | Nov 30, 2023 | ($278.2K) | Mar 19, 2025 |
| FY2023 | Nov 30, 2022 | ($280.3K) | Mar 14, 2024 |
| FY2022 | Nov 30, 2021 | ($209.7K) | Feb 24, 2023 |
| FY2021 | Nov 30, 2020 | ($13.5K) | Feb 25, 2022 |
| FY2020 | Nov 30, 2019 | ($23.0K) | Mar 15, 2021 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $395.1K | Mar 2, 2026 |
| FY2025 | Nov 30, 2024 | $1.15M | Mar 2, 2026 |
| FY2023 | Nov 30, 2023 | $194.3K | Mar 19, 2025 |
| FY2023 | Nov 30, 2022 | $712.6K | Mar 14, 2024 |
| FY2022 | Nov 30, 2021 | $2.35M | Feb 24, 2023 |
| FY2021 | Nov 30, 2020 | $12.11M | Feb 25, 2022 |
| FY2020 | Nov 30, 2019 | $641.2K | Mar 15, 2021 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $278.2K | Mar 2, 2026 |
| FY2025 | Nov 30, 2024 | $206.3K | Mar 2, 2026 |
| FY2023 | Nov 30, 2023 | $16.2K | Mar 19, 2025 |
| FY2023 | Nov 30, 2022 | $34.1K | Mar 14, 2024 |
| FY2022 | Nov 30, 2021 | $29.6K | Feb 24, 2023 |
| FY2021 | Nov 30, 2020 | $39.2K | Feb 25, 2022 |
| FY2020 | Nov 30, 2019 | $106.4K | Mar 15, 2021 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $116.9K | Mar 2, 2026 |
| FY2025 | Nov 30, 2024 | $940.3K | Mar 2, 2026 |
| FY2025 | Nov 30, 2023 | $178.1K | Mar 2, 2026 |
| FY2023 | Nov 30, 2022 | $678.5K | Mar 19, 2025 |
| FY2023 | Nov 30, 2021 | $2.32M | Mar 14, 2024 |
| FY2022 | Nov 30, 2020 | $12.07M | Feb 24, 2023 |
| FY2021 | Nov 30, 2019 | $534.7K | Feb 25, 2022 |
| FY2021 | Nov 30, 2018 | $107.3K | Feb 25, 2022 |
| FY2021 | Nov 30, 2017 | $18.2K | Feb 25, 2022 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | ($1.06M) | Mar 2, 2026 |
| FY2025 | Nov 30, 2024 | ($114.3K) | Mar 2, 2026 |
| FY2023 | Nov 30, 2023 | ($756.5K) | Mar 19, 2025 |
| FY2023 | Nov 30, 2022 | ($256.1K) | Mar 14, 2024 |
| FY2022 | Nov 30, 2021 | $1.46M | Feb 24, 2023 |
| FY2021 | Nov 30, 2020 | $11.22M | Feb 25, 2022 |
| FY2020 | Nov 30, 2019 | ($300.2K) | Mar 15, 2021 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Nov 30, 2021 | $524.7K | Feb 25, 2022 |
| FY2021 | Nov 30, 2020 | $598.8K | Feb 25, 2022 |
| FY2021 | Nov 30, 2019 | $559.9K | Feb 25, 2022 |
| FY2020 | Nov 30, 2018 | $121.1K | Mar 15, 2021 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | 0 | Mar 2, 2026 |
| FY2025 | Nov 30, 2024 | 0 | Mar 2, 2026 |
| FY2023 | Nov 30, 2023 | 0 | Mar 14, 2024 |
| FY2023 | Nov 30, 2022 | 0 | Mar 14, 2024 |
| FY2022 | Nov 30, 2021 | 0 | Feb 24, 2023 |
| FY2021 | Nov 30, 2020 | 0 | Feb 25, 2022 |
| FY2020 | Nov 30, 2019 | 0 | Mar 15, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | 0 | Mar 2, 2026 |
| FY2025 | Nov 30, 2024 | 0 | Mar 2, 2026 |
| FY2023 | Nov 30, 2023 | 0 | Mar 14, 2024 |
| FY2023 | Nov 30, 2022 | 0 | Mar 14, 2024 |
| FY2022 | Nov 30, 2021 | 0 | Feb 24, 2023 |
| FY2021 | Nov 30, 2020 | 0 | Feb 25, 2022 |
| FY2020 | Nov 30, 2019 | 0 | Mar 15, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | 27.94M | Mar 2, 2026 |
| FY2025 | Nov 30, 2024 | 27.94M | Mar 2, 2026 |
| FY2023 | Nov 30, 2023 | 27.94M | Mar 19, 2025 |
| FY2023 | Nov 30, 2022 | 27.94M | Mar 14, 2024 |
| FY2022 | Nov 30, 2021 | 27.92M | Feb 24, 2023 |
| FY2021 | Nov 30, 2020 | 27.91M | Feb 25, 2022 |
| FY2020 | Nov 30, 2019 | 27.90M | Mar 15, 2021 |
| FY2020 | Apr 16, 2019 | 144.75M | Mar 15, 2021 |